Related Experiment Videos
PI3-kinase inhibition: a target for drug development?
1The Ludwig Institute for Cancer Research and Department of Oncology, Royal Free and University College London Medical School, 91 Riding House Street, London, UK W1W 7BS. rstein@ludwig.ucl.ac.uk
Molecular Medicine Today
|August 24, 2000
Summary
Phosphoinositide 3-kinases (PI3-kinases) regulate crucial cellular functions like motility and metabolism. Their role in diseases makes them promising drug targets, with potential for specialized inhibition.
Area of Science:
- Biochemistry and Molecular Biology
- Cellular Signaling
- Pharmacology
Background:
- Phosphoinositide 3-kinases (PI3-kinases) are enzymes critical for cellular processes.
- They generate second messengers regulating cell motility, proliferation, survival, and metabolism.
Purpose of the Study:
- To review PI3-kinase family members, their activation mechanisms, and influenced cellular events.
- To highlight PI3-kinases as drug targets for cancer, proliferative, inflammatory, and immunological diseases.
Main Methods:
- Literature review of PI3-kinase family and related kinases.
- Analysis of PI3-kinase involvement in cellular processes and disease.
- Examination of evidence for isoform specialization and targeted inhibition.
Main Results:
- PI3-kinases are ubiquitously expressed and regulate fundamental cellular activities.
- Their dysregulation is implicated in various diseases, notably cancer and inflammatory conditions.
- Functional specialization among PI3-kinase isoforms suggests potential for selective drug development.
Conclusions:
- PI3-kinases are central regulators of cell function with significant therapeutic potential.
- Targeting PI3-kinases offers a promising strategy for treating proliferative and inflammatory diseases.
- Selective inhibition of PI3-kinase isoforms may allow for effective treatment with reduced toxicity.